Extra cycles of neoadjuvant chemotherapy before interval surgery for ovarian cancer: the more the merrier or too much of a good thing? | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article info

other Versions

You are currently viewing an earlier version of this article (July 20, 2022).
View the most recent version of this article

Editorial

Extra cycles of neoadjuvant chemotherapy before interval surgery for ovarian cancer: the more the merrier or too much of a good thing?

Free

Authors

Roni Nitecki Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Alexander Melamed Department of Obstetrics and Gynecology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA PubMed articles Google scholar articles

Correspondence to Dr Alexander Melamed, Department of Obstetrics and Gynecology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA; am5195{at}cumc.columbia.edu

Citation

Nitecki R, Melamed A

Extra cycles of neoadjuvant chemotherapy before interval surgery for ovarian cancer: the more the merrier or too much of a good thing?

International Journal of Gynecologic Cancer Published Online First: 20 July 2022. doi: 10.1136/ijgc-2022-003796

Publication history

Received June 24, 2022
Accepted June 27, 2022
First published July 20, 2022.

Article Versions

You are currently viewing a Previous version of this article (20 July 2022).
View the most recent version of this article

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.